Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Comparing two pacing methods to prevent heart dysfunction

Official title: Left Septal Pacing or Left Bundle Branch Pacing to Avoid Left Ventricle Systolic Dysfunction. A Multicenter Randomized Trial From the STAY Investigators

Run by Parc de Salut Mar · NCT06707662 · Data updated 2026-11-12

This study is testing if two new pacing methods for heart patients can better protect heart function compared to the traditional method.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment150 (estimated)
SponsorParc de Salut Mar
Academic / other
Locations1 site (Barcelona)
StatusRecruiting
StartedJanuary 1, 2025
Main results expectedDecember 1, 2026
Study endsDecember 1, 2026
Registry record updatedFebruary 11, 2025
Trial IDNCT06707662 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with preserved or mildly deteriorated left ventricular ejection fraction and a high burden of expected ventricular pacing.

Probably not a fit

Patients with severe left ventricular dysfunction, those requiring implantable cardioverter defibrillators, or those with recent significant cardiac events may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to compare the effectiveness of left septal pacing (LVSP) and left bundle branch pacing (LBBP) against conventional right ventricular apical pacing (RVAP) in patients with high-degree atrioventricular block. The study will involve a multi-center, prospective, randomized design, where participants will be assigned to one of the pacing methods during pacemaker implantation. The primary goal is to determine whether LVSP can better preserve left ventricular function compared to LBBP and RVAP in patients with preserved or mildly deteriorated left ventricular ejection fraction. Outcomes will be assessed over a 12-month period following the procedure.

Why it matters

Potential benefit: If successful, this study could lead to improved heart function and reduced heart failure admissions for patients requiring pacemakers.

How similar studies have gone: Previous studies have shown success with conduction system pacing approaches, indicating potential for this trial's methodology.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age of 18 years or more.
2. Preserved or mild deteriorated LVEF (Simpson \>40%) assessed by a recent (\<1 month before implantation) transthoracic echocardiography.
3. Indication for pacing based on the presence of a high degree AVB, and consequently with an anticipated high burden of ventricular pacing (\>80%).
4. Life expectancy of more than 12 months and capability to understand the protocol, signing informed consent form, and complying with follow-up.

Exclusion Criteria:

1. Patients with indication for implantable cardioverter defibrillator device.
2. Patients with indication for a CRT device, with LVEF \<40%.
3. Patients with previous severe LVD (Simpson LVEF \<30%) and a recovered LVEF.
4. History of myocardial infarction/revascularization or cardiac surgery within 6 months before randomization.
5. Pregnancy, active cancer treatment, or participation in another clinical trial with active treatment.

Where it's running

  • Hospital del Mar - IMIM
    Barcelona, Spain
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • SPIKE FLOW endocardial pacing lead safety and performance study

    This study tests whether the SPIKE FLOW temporary endocardial pacing lead is safe and effective in adults needing temporary pacing during heart-related conditions.

    Recruiting at 2 sites FIAB SpA · Acquaviva delle Fonti, Bari and 2 other locations · NCT07820072

  • Micra AV2 leadless pacemaker to improve AV synchrony in AV block

    This study will test whether the Micra AV2 leadless pacemaker improves AV synchrony and is safe for adults with high‑degree AV block who have normal sinus rhythm.

    Recruiting Universitaire Ziekenhuizen KU Leuven · Leuven, Flemish Brabant · NCT07356505

  • LivIQ leadless pacemaker system for ventricular pacing

    This trial will test the LivIQ leadless pacemaker in adults who need ventricular pacing (VVI or VDD) to see if it is safe and maintains appropriate heart rhythm and AV timing.

    Recruiting at 41 sites Biotronik, Inc. · Burlingame, California and 42 other locations · NCT07118358

  • Comparing two pacing methods after heart valve surgery

    This study is testing whether a new way of pacing the heart after valve surgery can help patients feel better and have better heart function compared to a standard method.

    Recruiting Hospital Clinic of Barcelona · Barcelona · NCT06197503

  • Comparing His and Left Bundle Branch Pacing for Heart Failure

    This study is testing whether a new way of pacing the heart can help people with heart failure feel better and stay out of the hospital compared to the usual treatment.

    Recruiting at 62 sites Baylor College of Medicine · Gilbert, Arizona and 70 other locations · NCT05650658

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.